RetinalGenix Technologies Inc.
RTGN
$3.20
-$0.35-9.86%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.55% | 12.41% | -10.57% | 32.26% | -34.56% |
| Total Depreciation and Amortization | 0.00% | -14.29% | 0.00% | -22.22% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.90% | 6.50% | 4.61% | -38.15% | 71.17% |
| Change in Net Operating Assets | 119.35% | -76.94% | 4,380.95% | -94.37% | 68.78% |
| Cash from Operations | -23.51% | 25.38% | 25.69% | -0.43% | 24.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -2,329.03% | -93.82% | 43.84% | 128.10% | 123.22% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 112.00% | 16.28% | -42.67% | 53.06% | -67.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38.60% | -24.30% | -26.34% | 63.05% | -52.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,200.00% | 75.86% | -26.09% | 96.85% | -835.90% |